首页 > 最新文献

Acta Anaesthesiologica Scandinavica最新文献

英文 中文
Of storks and babies and secondary analyses. 关于鹳鸟和婴儿以及二次分析。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2024-07-01 Epub Date: 2024-03-21 DOI: 10.1111/aas.14410
Ehrenfried Schindler, Jacob Karlsson, Thomas Engelhardt
{"title":"Of storks and babies and secondary analyses.","authors":"Ehrenfried Schindler, Jacob Karlsson, Thomas Engelhardt","doi":"10.1111/aas.14410","DOIUrl":"10.1111/aas.14410","url":null,"abstract":"","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140178943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The number of comorbidities as an important cofactor to ASA class in predicting postoperative outcome: An international multicentre cohort study. 合并症数量是预测术后结果的 ASA 分级的重要辅助因素:一项国际多中心队列研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-07-01 DOI: 10.1111/aas.14494
Christian A Grob, Luzius W Angehrn, Mark Kaufmann, Dieter Hahnloser, Michael Winiker, Thomas O Erb, Sonja Joller, Philippe Schumacher, Heinz R Bruppacher, Gregory O'Grady, Jonathon Murtagh, Larsa Gawria, Kim Albers, Sonja Meier, Anna R Heilbronner Samuel, Christian Schindler, Luzius A Steiner, Salome Dell-Kuster

Background: Multimorbidity is a growing burden in our ageing society and is associated with perioperative morbidity and mortality. Despite several modifications to the ASA physical status classification, multimorbidity as such is still not considered. Thus, the aim of this study was to quantify the burden of comorbidities in perioperative patients and to assess, independent of ASA class, its potential influence on perioperative outcome.

Methods: In a subpopulation of the prospective ClassIntra® validation study from eight international centres, type and severity of anaesthesia-relevant comorbidities were additionally extracted from electronic medical records for the current study. Patients from the validation study were of all ages, undergoing any type of in-hospital surgery and were followed up until 30 days postoperatively to assess perioperative outcomes. Primary endpoint was the number of comorbidities across ASA classes. The associated postoperative length of hospital stay (pLOS) and Comprehensive Complication Index (CCI®) were secondary endpoints. On a scale from 0 (no complication) to 100 (death) the CCI® measures the severity of postoperative morbidity as a weighted sum of all postoperative complications.

Results: Of 1421 enrolled patients, the mean number of comorbidities significantly increased from 1.5 in ASA I (95% CI, 1.1-1.9) to 10.5 in ASA IV (95% CI, 8.3-12.7) patients. Furthermore, independent of ASA class, postoperative complications measured by the CCI® increased per each comorbidity by 0.81 (95% CI, 0.40-1.23) and so did pLOS (geometric mean ratio, 1.03; 95% CI, 1.01-1.06).

Conclusions: These data quantify the high prevalence of multimorbidity in the surgical population and show that the number of comorbidities is predictive of negative postoperative outcomes, independent of ASA class.

背景:在老龄化社会中,多病负担日益加重,并与围手术期的发病率和死亡率相关。尽管对 ASA 身体状况分类进行了多次修改,但仍未考虑到多病症本身。因此,本研究旨在量化围手术期患者的合并症负担,并评估合并症对围手术期结果的潜在影响(与 ASA 分级无关):方法:在八个国际中心进行的前瞻性 ClassIntra® 验证研究的一个子群中,从电子病历中额外提取了与麻醉相关的合并症的类型和严重程度,用于本次研究。验证研究中的患者不分年龄,接受任何类型的院内手术,并在术后 30 天前接受随访,以评估围手术期的效果。主要终点是各ASA等级合并症的数量。相关的术后住院时间(pLOS)和综合并发症指数(CCI®)是次要终点。CCI®指数从0(无并发症)到100(死亡),以所有术后并发症的加权总和来衡量术后发病率的严重程度:结果:在 1421 名入选患者中,合并症的平均数量从 ASA I 级患者的 1.5(95% CI,1.1-1.9)显著增加到 ASA IV 级患者的 10.5(95% CI,8.3-12.7)。此外,与ASA等级无关,CCI®测量的术后并发症每增加一种并发症就增加0.81(95% CI,0.40-1.23),pLOS也是如此(几何平均比,1.03;95% CI,1.01-1.06):这些数据量化了手术人群中多病的高发病率,并表明合并症的数量可预测术后的不良预后,与 ASA 分级无关。
{"title":"The number of comorbidities as an important cofactor to ASA class in predicting postoperative outcome: An international multicentre cohort study.","authors":"Christian A Grob, Luzius W Angehrn, Mark Kaufmann, Dieter Hahnloser, Michael Winiker, Thomas O Erb, Sonja Joller, Philippe Schumacher, Heinz R Bruppacher, Gregory O'Grady, Jonathon Murtagh, Larsa Gawria, Kim Albers, Sonja Meier, Anna R Heilbronner Samuel, Christian Schindler, Luzius A Steiner, Salome Dell-Kuster","doi":"10.1111/aas.14494","DOIUrl":"https://doi.org/10.1111/aas.14494","url":null,"abstract":"<p><strong>Background: </strong>Multimorbidity is a growing burden in our ageing society and is associated with perioperative morbidity and mortality. Despite several modifications to the ASA physical status classification, multimorbidity as such is still not considered. Thus, the aim of this study was to quantify the burden of comorbidities in perioperative patients and to assess, independent of ASA class, its potential influence on perioperative outcome.</p><p><strong>Methods: </strong>In a subpopulation of the prospective ClassIntra® validation study from eight international centres, type and severity of anaesthesia-relevant comorbidities were additionally extracted from electronic medical records for the current study. Patients from the validation study were of all ages, undergoing any type of in-hospital surgery and were followed up until 30 days postoperatively to assess perioperative outcomes. Primary endpoint was the number of comorbidities across ASA classes. The associated postoperative length of hospital stay (pLOS) and Comprehensive Complication Index (CCI®) were secondary endpoints. On a scale from 0 (no complication) to 100 (death) the CCI® measures the severity of postoperative morbidity as a weighted sum of all postoperative complications.</p><p><strong>Results: </strong>Of 1421 enrolled patients, the mean number of comorbidities significantly increased from 1.5 in ASA I (95% CI, 1.1-1.9) to 10.5 in ASA IV (95% CI, 8.3-12.7) patients. Furthermore, independent of ASA class, postoperative complications measured by the CCI® increased per each comorbidity by 0.81 (95% CI, 0.40-1.23) and so did pLOS (geometric mean ratio, 1.03; 95% CI, 1.01-1.06).</p><p><strong>Conclusions: </strong>These data quantify the high prevalence of multimorbidity in the surgical population and show that the number of comorbidities is predictive of negative postoperative outcomes, independent of ASA class.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged duration of action of suxamethonium in pregnant and postpartum patients: A registry study. 在孕妇和产后患者中延长舒血宁的作用时间:登记研究。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2024-07-01 Epub Date: 2024-03-24 DOI: 10.1111/aas.14413
Helene Dalsten, Vera Crone, Jacob Steinmetz, Christine L Rosager, Lars S Rasmussen, Matias Vested

Background: Suxamethonium is hydrolysed by butyrylcholinesterase (BChE) and a low BChE activity can result in a prolonged duration of action of suxamethonium. The BChE activity is reduced during pregnancy and postpartum period by up to 33%. However, it can also be reduced by mutations in the BChE gene. In this study, we assessed BChE activity and mutations in the BChE gene in pregnant and postpartum patients with prolonged duration of action of suxamethonium. It was hypothesised that at least 30% of patients with a low BChE activity did not have a mutation in the BChE gene.

Methods: In this registry study we focused on pregnant and postpartum patients with a history of prolonged duration of action of suxamethonium referred to the Danish Cholinesterase Research Unit (DCRU) between March 2007 and January 2023. Primary outcome was the proportion of patients without a mutation among patients with a low BChE activity. Secondary outcomes were the proportion of patients with a low BChE activity and the proportion of patients with a mutation out of the total number of patients.

Results: A total of 40 patients were included and among patients with a low BChE activity, 6% (95% CI: 1%-21%) did not have a mutation. Out of the total number of included patients referred to the DCRU, 90% (95% CI: 76%-97%) had a mutation and 94% (95% CI: 80%-99%) had a low BChE activity.

Conclusion: Among pregnant and postpartum patients with a history of prolonged duration of action of suxamethonium and a low BChE activity, 6% did not have a mutation in the BChE gene. Our findings suggest that during pregnancy and postpartum clinically relevant prolonged duration of action of suxamethonium rarely occurs in genotypically normal patients.

背景:舒血宁会被丁酰胆碱酯酶(BChE)水解,BChE活性低会导致舒血宁的作用时间延长。在妊娠期和产后,BChE 的活性会降低 33%。然而,BChE 基因突变也会导致其活性降低。在这项研究中,我们评估了妊娠期和产后舒血宁作用时间延长患者的 BChE 活性和 BChE 基因突变情况。我们假设至少有 30% 的 BChE 活性低的患者没有 BChE 基因突变:在这项登记研究中,我们重点研究了 2007 年 3 月至 2023 年 1 月期间转诊至丹麦胆碱酯酶研究单位(DCRU)的、有舒血宁作用时间延长病史的孕妇和产后患者。主要结果是在 BChE 活性较低的患者中没有突变的患者比例。次要结果是低 BChE 活性患者的比例和突变患者占患者总数的比例:共纳入了40名患者,在BChE活性低的患者中,6%(95% CI:1%-21%)的患者没有突变。在转诊至 DCRU 的所有纳入患者中,90%(95% CI:76%-97%)的患者存在基因突变,94%(95% CI:80%-99%)的患者 BChE 活性较低:结论:在有舒血宁作用时间延长史和 BChE 活性低的妊娠期和产后患者中,6% 的人没有发生 BChE 基因突变。我们的研究结果表明,在妊娠期和产后,基因型正常的患者很少会出现与临床相关的舒血宁作用时间延长的情况。
{"title":"Prolonged duration of action of suxamethonium in pregnant and postpartum patients: A registry study.","authors":"Helene Dalsten, Vera Crone, Jacob Steinmetz, Christine L Rosager, Lars S Rasmussen, Matias Vested","doi":"10.1111/aas.14413","DOIUrl":"10.1111/aas.14413","url":null,"abstract":"<p><strong>Background: </strong>Suxamethonium is hydrolysed by butyrylcholinesterase (BChE) and a low BChE activity can result in a prolonged duration of action of suxamethonium. The BChE activity is reduced during pregnancy and postpartum period by up to 33%. However, it can also be reduced by mutations in the BChE gene. In this study, we assessed BChE activity and mutations in the BChE gene in pregnant and postpartum patients with prolonged duration of action of suxamethonium. It was hypothesised that at least 30% of patients with a low BChE activity did not have a mutation in the BChE gene.</p><p><strong>Methods: </strong>In this registry study we focused on pregnant and postpartum patients with a history of prolonged duration of action of suxamethonium referred to the Danish Cholinesterase Research Unit (DCRU) between March 2007 and January 2023. Primary outcome was the proportion of patients without a mutation among patients with a low BChE activity. Secondary outcomes were the proportion of patients with a low BChE activity and the proportion of patients with a mutation out of the total number of patients.</p><p><strong>Results: </strong>A total of 40 patients were included and among patients with a low BChE activity, 6% (95% CI: 1%-21%) did not have a mutation. Out of the total number of included patients referred to the DCRU, 90% (95% CI: 76%-97%) had a mutation and 94% (95% CI: 80%-99%) had a low BChE activity.</p><p><strong>Conclusion: </strong>Among pregnant and postpartum patients with a history of prolonged duration of action of suxamethonium and a low BChE activity, 6% did not have a mutation in the BChE gene. Our findings suggest that during pregnancy and postpartum clinically relevant prolonged duration of action of suxamethonium rarely occurs in genotypically normal patients.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140206156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey on perioperative red blood cell transfusion trigger strategies for pediatric patients in the Nordic countries. 北欧国家儿科患者围手术期输注红细胞触发策略调查。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2024-07-01 Epub Date: 2024-03-28 DOI: 10.1111/aas.14416
Theodor S Sigurdsson, Emilie Øberg, Janne Roshauw, Bryndis Snorradottir, Lars Broksø Holst

Background: Transfusion of red blood cells (RBC) to rapidly increase hemoglobin levels have been associated with increased risks and worse outcomes in critically ill children. The international TAXI consensus from 2018 (pediatric critical care transfusion and anemia expertise initiative) recommended restrictive RBC transfusion strategies in pediatric patients.

Objective: To elucidate physicians perioperative RBC transfusion trigger strategies for pediatric patients in the Nordic countries and to investigate what factors influence the decision to transfuse this group of patients.

Methods: An electronic web-based survey designed by the TransfUsion triggers in Pediatric perioperAtive Care (TUPAC) initiative including six different clinical scenarios was sent to anesthesiologist treating pediatric patients at university hospitals in the Nordic countries on February 1, 2023 and closed May 1, 2023.

Results: The study had a response rate of 67.7% (180 responders out of 266 contacted). Median hemoglobin thresholds triggering RBC transfusions were 7.0 [IQR, 7.0-7.3] g/dL in a stable young child (1-year-old), 7.0 [IQR, 7.0-7.0] g/dL in the stable older child (5-year-old), 8.5 [IQR, 8.0-9.0] g/dL in the older child with cardiac disease, 9.0 [IQR, 8.0-10.0] g/dL the older child with traumatic brain injury, 8.0 [IQR, 7.3-9.0] g/dL in stabilized older child with septic shock and 8.0 [IQR, 7.0-9.0] g/dL in the older child with active but non-life-threatening bleeding. Apart from specific hemoglobin level, RBC transfusions were mostly triggered by high lactate level (74.2%), increasing heart rate (68.0%), prolonged capillary refill time (48.3%), and lowered blood pressure (47.8%). No statistical difference was found between the Nordic countries, work experience, or enrollment in a pediatric anesthesia fellowship program regarding RBC transfusion strategies.

Conclusions: Anesthesiologists in the Nordic countries report restrictive perioperative RBC transfusion strategies for children that are mostly in agreement with the international TAXI recommendations. However, RBC transfusions strategies were modified to be guided by more liberal trigger levels when pediatric patients presented with severe comorbidity such as severe sepsis, septic shock, and non-life-threatening bleeding.

背景:输注红细胞(RBC)以快速提高血红蛋白水平与危重症儿童风险增加和预后恶化有关。2018 年的国际 TAXI 共识(儿科危重症输血和贫血专业倡议)建议对儿科患者采取限制性 RBC 输血策略:阐明北欧国家儿科患者围手术期RBC输血的医生触发策略,并调查哪些因素会影响这类患者的输血决定:方法:由儿科围手术期护理输血触发器(TUPAC)倡议设计的一项电子网络调查于2023年2月1日发送给北欧国家大学医院治疗儿科患者的麻醉医师,调查包括六种不同的临床情景,并于2023年5月1日结束:结果:研究的响应率为 67.7%(266 位联系者中有 180 位响应者)。引发输注红细胞的血红蛋白阈值中位数分别为:病情稳定的幼儿(1 岁)7.0 [IQR, 7.0-7.3] g/dL;病情稳定的年长儿童(5 岁)7.0 [IQR, 7.0-7.0] g/dL;患有心脏病的年长儿童 8.5 [IQR, 8.0-9.0] g/dL;患有心脏病的年长儿童 9.0 [IQR, 8.0-9.0] g/dL。患有脓毒性休克、病情稳定的大龄儿童为 8.0 [IQR, 7.3-9.0] g/dL,患有活动性出血但无生命危险的大龄儿童为 8.0 [IQR, 7.0-9.0] g/dL。除了特定的血红蛋白水平外,引发输注红细胞的原因还包括乳酸水平过高(74.2%)、心率加快(68.0%)、毛细血管再充盈时间延长(48.3%)和血压降低(47.8%)。在输注红细胞的策略方面,北欧国家之间、工作经验之间以及是否参加过儿科麻醉奖学金项目之间均未发现统计学差异:结论:北欧国家的麻醉医师报告称,儿童围术期限制性RBC输血策略与国际TAXI建议基本一致。然而,当儿科患者出现严重合并症(如严重败血症、脓毒性休克和非危及生命的出血)时,RBC 输血策略会根据更宽松的触发水平进行调整。
{"title":"A survey on perioperative red blood cell transfusion trigger strategies for pediatric patients in the Nordic countries.","authors":"Theodor S Sigurdsson, Emilie Øberg, Janne Roshauw, Bryndis Snorradottir, Lars Broksø Holst","doi":"10.1111/aas.14416","DOIUrl":"10.1111/aas.14416","url":null,"abstract":"<p><strong>Background: </strong>Transfusion of red blood cells (RBC) to rapidly increase hemoglobin levels have been associated with increased risks and worse outcomes in critically ill children. The international TAXI consensus from 2018 (pediatric critical care transfusion and anemia expertise initiative) recommended restrictive RBC transfusion strategies in pediatric patients.</p><p><strong>Objective: </strong>To elucidate physicians perioperative RBC transfusion trigger strategies for pediatric patients in the Nordic countries and to investigate what factors influence the decision to transfuse this group of patients.</p><p><strong>Methods: </strong>An electronic web-based survey designed by the TransfUsion triggers in Pediatric perioperAtive Care (TUPAC) initiative including six different clinical scenarios was sent to anesthesiologist treating pediatric patients at university hospitals in the Nordic countries on February 1, 2023 and closed May 1, 2023.</p><p><strong>Results: </strong>The study had a response rate of 67.7% (180 responders out of 266 contacted). Median hemoglobin thresholds triggering RBC transfusions were 7.0 [IQR, 7.0-7.3] g/dL in a stable young child (1-year-old), 7.0 [IQR, 7.0-7.0] g/dL in the stable older child (5-year-old), 8.5 [IQR, 8.0-9.0] g/dL in the older child with cardiac disease, 9.0 [IQR, 8.0-10.0] g/dL the older child with traumatic brain injury, 8.0 [IQR, 7.3-9.0] g/dL in stabilized older child with septic shock and 8.0 [IQR, 7.0-9.0] g/dL in the older child with active but non-life-threatening bleeding. Apart from specific hemoglobin level, RBC transfusions were mostly triggered by high lactate level (74.2%), increasing heart rate (68.0%), prolonged capillary refill time (48.3%), and lowered blood pressure (47.8%). No statistical difference was found between the Nordic countries, work experience, or enrollment in a pediatric anesthesia fellowship program regarding RBC transfusion strategies.</p><p><strong>Conclusions: </strong>Anesthesiologists in the Nordic countries report restrictive perioperative RBC transfusion strategies for children that are mostly in agreement with the international TAXI recommendations. However, RBC transfusions strategies were modified to be guided by more liberal trigger levels when pediatric patients presented with severe comorbidity such as severe sepsis, septic shock, and non-life-threatening bleeding.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140317593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-sensitive troponinT, interleukin-8, and interleukin-6 link with post-surgery risk in infant heart surgery. 高敏肌钙蛋白T、白细胞介素-8和白细胞介素-6与婴儿心脏手术后的风险有关。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-07-01 Epub Date: 2024-03-26 DOI: 10.1111/aas.14405
Elin M Thorlacius, Juho Keski-Nisula, Maria Vistnes, Tiina Ojala, Mattias Molin, Mats Synnergren, Birgitta S Romlin, Sven-Erik Ricksten, Håkan Wåhlander, Albert Gyllencreutz Castellheim

Background: This study focuses on biomarkers in infants after open heart surgery, and examines the association of high-sensitive troponin T (hs-cTnT), interleukin-6 (IL-6), and interleukin-8 (IL-8) with postoperative acute kidney injury (AKI), ventilatory support time and need of vasoactive drugs.

Methods: Secondary exploratory study from a double-blinded clinical randomized trial (Mile-1) on 70 infants undergoing open heart surgery with cardiopulmonary bypass (CPB). In this sub-study, the entire study population was examined without considering the study drugs. The biomarkers' peak concentration (highest concentration at 2 or 6 h post-CPB) were used for statistical analyses.

Results: Peak IL-8, hs-cTnT, and IL-6 occurred at 2 h post-CPB for 96%, 79%, and 63% of the patients, respectively. The odds ratio of developing AKI2-3 for IL-6 > 293 pg/mL was 23.4 (95% CI 5.3;104.0), for IL-8 > 100 pg/mL it was 11.5 (3.0;44.2), and for hs-cTnT >5597 pg/mL it was 6.1 (1.5; 24.5). In more than two third of the patients with the highest peak concentrations of IL-8, IL-6, and hs-cTnT, there was a need for ventilatory support for >24 h and use of vasoactive drugs at 24 h post-CPB, while in less than one third of the patients with the lowest peak concentrations of IL-8 and hs-cTnT such requirements were observed.

Conclusions: The peak biomarker concentrations and CPB-time strongly predicted AKI2-3, with IL-6 and IL-8 emerging as strongest predictors. Furthermore, our findings suggest that measuring hs-cTnT and IL-8 just 2 h post-CPB-weaning may assist in identifying infants suitable for early extubation and highlight those at risk of prolonged ventilation.

研究背景本研究关注开胸手术后婴儿的生物标志物,探讨高敏肌钙蛋白T(hs-cTnT)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)与术后急性肾损伤(AKI)、通气支持时间和血管活性药物需求的关系:对 70 名接受心肺旁路(CPB)开胸手术的婴儿进行的双盲临床随机试验(Mile-1)的二次探索性研究。在这项子研究中,在不考虑研究药物的情况下对整个研究人群进行了检查。生物标志物的峰值浓度(心肺旁路术后 2 或 6 小时的最高浓度)用于统计分析:结果:96%、79% 和 63% 的患者 IL-8、hs-cTnT 和 IL-6 的峰值分别出现在 CPB 后 2 小时。IL-6 > 293 pg/mL 发生 AKI2-3 的几率比为 23.4 (95% CI 5.3;104.0),IL-8 > 100 pg/mL 的几率比为 11.5 (3.0;44.2),hs-cTnT > 5597 pg/mL 的几率比为 6.1 (1.5; 24.5)。在IL-8、IL-6和hs-cTnT峰值浓度最高的患者中,超过三分之二的患者在心肺复苏术后24小时内需要呼吸机支持和使用血管活性药物,而在IL-8和hs-cTnT峰值浓度最低的患者中,只有不到三分之一的患者需要使用血管活性药物:结论:生物标志物的峰值浓度和 CPB 时间对 AKI2-3 有很强的预测作用,其中 IL-6 和 IL-8 的预测作用最强。此外,我们的研究结果表明,在 CPB 拔管后 2 小时内测量 hs-cTnT 和 IL-8,有助于识别适合早期拔管的婴儿,并突出那些有延长通气风险的婴儿。
{"title":"High-sensitive troponinT, interleukin-8, and interleukin-6 link with post-surgery risk in infant heart surgery.","authors":"Elin M Thorlacius, Juho Keski-Nisula, Maria Vistnes, Tiina Ojala, Mattias Molin, Mats Synnergren, Birgitta S Romlin, Sven-Erik Ricksten, Håkan Wåhlander, Albert Gyllencreutz Castellheim","doi":"10.1111/aas.14405","DOIUrl":"10.1111/aas.14405","url":null,"abstract":"<p><strong>Background: </strong>This study focuses on biomarkers in infants after open heart surgery, and examines the association of high-sensitive troponin T (hs-cTnT), interleukin-6 (IL-6), and interleukin-8 (IL-8) with postoperative acute kidney injury (AKI), ventilatory support time and need of vasoactive drugs.</p><p><strong>Methods: </strong>Secondary exploratory study from a double-blinded clinical randomized trial (Mile-1) on 70 infants undergoing open heart surgery with cardiopulmonary bypass (CPB). In this sub-study, the entire study population was examined without considering the study drugs. The biomarkers' peak concentration (highest concentration at 2 or 6 h post-CPB) were used for statistical analyses.</p><p><strong>Results: </strong>Peak IL-8, hs-cTnT, and IL-6 occurred at 2 h post-CPB for 96%, 79%, and 63% of the patients, respectively. The odds ratio of developing AKI2-3 for IL-6 > 293 pg/mL was 23.4 (95% CI 5.3;104.0), for IL-8 > 100 pg/mL it was 11.5 (3.0;44.2), and for hs-cTnT >5597 pg/mL it was 6.1 (1.5; 24.5). In more than two third of the patients with the highest peak concentrations of IL-8, IL-6, and hs-cTnT, there was a need for ventilatory support for >24 h and use of vasoactive drugs at 24 h post-CPB, while in less than one third of the patients with the lowest peak concentrations of IL-8 and hs-cTnT such requirements were observed.</p><p><strong>Conclusions: </strong>The peak biomarker concentrations and CPB-time strongly predicted AKI2-3, with IL-6 and IL-8 emerging as strongest predictors. Furthermore, our findings suggest that measuring hs-cTnT and IL-8 just 2 h post-CPB-weaning may assist in identifying infants suitable for early extubation and highlight those at risk of prolonged ventilation.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study. 重症监护病房感染的经验性碳青霉烯类或哌拉西林/他唑巴坦:一项国际回顾性队列研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-07-01 Epub Date: 2024-03-28 DOI: 10.1111/aas.14419
Nick Meier, Marie Warrer Munch, Anders Granholm, Anders Perner, Frederik Boëtius Hertz, Balasubramanian Venkatesh, Naomi E Hammond, Qiang Li, Liesbet De Bus, Jan De Waele, Evaldas Kauzonas, Fredrik Sjövall, Morten Hylander Møller, Marie Helleberg

Background: Critically ill patients in intensive care units (ICU) are frequently administered broad-spectrum antibiotics (e.g., carbapenems or piperacillin/tazobactam) for suspected or confirmed infections. This retrospective cohort study aimed to describe the use of carbapenems and piperacillin/tazobactam in two international, prospectively collected datasets.

Methods: We conducted a post hoc analysis of data from the "Adjunctive Glucocorticoid Therapy in Patients with Septic Shock" (ADRENAL) trial (n = 3713) and the "Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure" (DIANA) study (n = 1488). The primary outcome was the proportion of patients receiving initial antibiotic treatment with carbapenems and piperacillin/tazobactam. Secondary outcomes included mortality, days alive and out of ICU and ICU length of stay at 28 days.

Results: In the ADRENAL trial, carbapenems were used in 648 out of 3713 (17%), whereas piperacillin/tazobactam was used in 1804 out of 3713 (49%) participants. In the DIANA study, carbapenems were used in 380 out of 1480 (26%), while piperacillin/tazobactam was used in 433 out of 1488 (29%) participants. Mortality at 28 days was 23% for patients receiving carbapenems and 24% for those receiving piperacillin/tazobactam in ADRENAL and 23% and 19%, respectively, in DIANA. We noted variations in secondary outcomes; in DIANA, patients receiving carbapenems had a median of 13 days alive and out of ICU compared with 18 days among those receiving piperacillin/tazobactam. In ADRENAL, the median hospital length of stay was 27 days for patients receiving carbapenems and 21 days for those receiving piperacillin/tazobactam.

Conclusions: In this post hoc analysis of ICU patients with infections, we found widespread initial use of carbapenems and piperacillin/tazobactam in international ICUs, with the latter being more frequently used. Randomized clinical trials are needed to assess if the observed variations in outcomes may be drug-related effects or due to confounders.

背景:重症监护室(ICU)中的重症患者经常因疑似或确诊感染而使用广谱抗生素(如碳青霉烯类或哌拉西林/他唑巴坦)。这项回顾性队列研究旨在描述两个国际前瞻性数据集中碳青霉烯类和哌拉西林/他唑巴坦的使用情况:我们对 "脓毒性休克患者辅助糖皮质激素治疗"(ADRENAL)试验(3713 人)和 "重症患者抗菌药物降级和临床治愈评估"(DIANA)研究(1488 人)的数据进行了事后分析。主要结果是接受碳青霉烯类和哌拉西林/他唑巴坦初始抗生素治疗的患者比例。次要结果包括死亡率、存活天数、离开重症监护室天数和重症监护室住院时间(28 天):在 ADRENAL 试验中,3713 名参与者中有 648 人(17%)使用了碳青霉烯类药物,而 3713 名参与者中有 1804 人(49%)使用了哌拉西林/他唑巴坦。在 DIANA 研究中,1480 位参与者中有 380 位(26%)使用了碳青霉烯类,而 1488 位参与者中有 433 位(29%)使用了哌拉西林/他唑巴坦。在 ADRENAL 中,接受碳青霉烯类治疗的患者在 28 天内的死亡率为 23%,接受哌拉西林/他唑巴坦治疗的患者为 24%,而在 DIANA 中分别为 23% 和 19%。我们注意到次要结果存在差异;在 DIANA,接受碳青霉烯类治疗的患者存活和离开重症监护室的时间中位数为 13 天,而接受哌拉西林/他唑巴坦治疗的患者存活和离开重症监护室的时间中位数为 18 天。在 ADRENAL 中,接受碳青霉烯类治疗的患者的中位住院时间为 27 天,而接受哌拉西林/他唑巴坦治疗的患者的中位住院时间为 21 天:在这项对重症监护病房感染患者进行的事后分析中,我们发现国际重症监护病房广泛使用碳青霉烯类和哌拉西林/他唑巴坦,其中后者的使用频率更高。需要进行随机临床试验,以评估观察到的结果差异可能与药物有关,也可能是由于混杂因素造成的。
{"title":"Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study.","authors":"Nick Meier, Marie Warrer Munch, Anders Granholm, Anders Perner, Frederik Boëtius Hertz, Balasubramanian Venkatesh, Naomi E Hammond, Qiang Li, Liesbet De Bus, Jan De Waele, Evaldas Kauzonas, Fredrik Sjövall, Morten Hylander Møller, Marie Helleberg","doi":"10.1111/aas.14419","DOIUrl":"10.1111/aas.14419","url":null,"abstract":"<p><strong>Background: </strong>Critically ill patients in intensive care units (ICU) are frequently administered broad-spectrum antibiotics (e.g., carbapenems or piperacillin/tazobactam) for suspected or confirmed infections. This retrospective cohort study aimed to describe the use of carbapenems and piperacillin/tazobactam in two international, prospectively collected datasets.</p><p><strong>Methods: </strong>We conducted a post hoc analysis of data from the \"Adjunctive Glucocorticoid Therapy in Patients with Septic Shock\" (ADRENAL) trial (n = 3713) and the \"Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure\" (DIANA) study (n = 1488). The primary outcome was the proportion of patients receiving initial antibiotic treatment with carbapenems and piperacillin/tazobactam. Secondary outcomes included mortality, days alive and out of ICU and ICU length of stay at 28 days.</p><p><strong>Results: </strong>In the ADRENAL trial, carbapenems were used in 648 out of 3713 (17%), whereas piperacillin/tazobactam was used in 1804 out of 3713 (49%) participants. In the DIANA study, carbapenems were used in 380 out of 1480 (26%), while piperacillin/tazobactam was used in 433 out of 1488 (29%) participants. Mortality at 28 days was 23% for patients receiving carbapenems and 24% for those receiving piperacillin/tazobactam in ADRENAL and 23% and 19%, respectively, in DIANA. We noted variations in secondary outcomes; in DIANA, patients receiving carbapenems had a median of 13 days alive and out of ICU compared with 18 days among those receiving piperacillin/tazobactam. In ADRENAL, the median hospital length of stay was 27 days for patients receiving carbapenems and 21 days for those receiving piperacillin/tazobactam.</p><p><strong>Conclusions: </strong>In this post hoc analysis of ICU patients with infections, we found widespread initial use of carbapenems and piperacillin/tazobactam in international ICUs, with the latter being more frequently used. Randomized clinical trials are needed to assess if the observed variations in outcomes may be drug-related effects or due to confounders.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140317595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depth of anesthesia monitoring in Norway-A web-based survey. 挪威的麻醉深度监测--基于网络的调查。
IF 2.1 4区 医学 Q2 Medicine Pub Date : 2024-07-01 Epub Date: 2024-03-29 DOI: 10.1111/aas.14420
Anders Aasheim, Leiv Arne Rosseland, Ann-Chatrin Linqvist Leonardsen, Luis Romundstad

Background: The bispectral index (BIS) monitor is the most frequently used electroencephalogram (EEG)-based depth of anesthesia (DoA) technology in Norwegian hospitals. However, there is limited knowledge regarding the extent and clinical impact of its use and how anesthesiologists and nurse anesthetists use the information provided by the DoA monitors in their clinical practice.

Methods: This cross-sectional survey on the use of DoA monitors in Norway used a web-based questionnaire distributed to anesthesia personnel in all hospitals in Norway. Participation was voluntary and anonymized, and the web form could not track IP sources or respondents' locations.

Results: Three hundred and ninety-one nurse anesthetists (n = 324) and anesthesiologists (n = 67) responded. Among the EEG-based DoA monitoring tools, BIS was most often used to observe and assess patients' DoA (98%). Raw EEG waveform analysis (10%), EEG-spectrogram (9%), and suppression rate (10%) were seldom used. Twenty-seven percent of the anesthesia personnel were able to recognize a burst suppression pattern on EEG and its significance. Fifty-eight percent of the respondents considered clinical observations more reliable than BIS. Almost all respondents reported adjusting anesthetic dosage based on the BIS index values (80%). However, the anesthetic dose was more often increased (90%) because of high BIS index values than lowered (55%) because of low BIS index values.

Conclusion: Despite our respondents' extensive use of DoA monitoring, the anesthesia personnel in our survey did not use all the information and the potential to guide the titration of anesthetics the DoA monitors provide. Thus, anesthesia personnel could generally benefit from increased knowledge of how EEG-based DoA monitoring can be used to assess and determine individual patients' need for anesthetic medication.

背景:双谱指数(BIS)监测仪是挪威医院最常用的基于脑电图(EEG)的麻醉深度(DoA)技术。然而,人们对其使用程度和临床影响以及麻醉医师和麻醉护士在临床实践中如何使用麻醉深度监测仪提供的信息了解有限:这项关于挪威 DoA 监护仪使用情况的横断面调查采用了网络问卷的形式,向挪威所有医院的麻醉人员发放了问卷。参与是自愿和匿名的,网络表格无法追踪 IP 来源或受访者的所在地:结果:391 名麻醉护士(n = 324)和麻醉医师(n = 67)做出了回应。在基于脑电图的 DoA 监测工具中,BIS 最常用于观察和评估患者的 DoA(98%)。很少使用原始脑电图波形分析(10%)、脑电图频谱图(9%)和抑制率(10%)。27% 的麻醉人员能够识别脑电图上的爆发抑制模式及其意义。58%的受访者认为临床观察比 BIS 更可靠。几乎所有受访者都表示会根据 BIS 指数值调整麻醉剂量(80%)。然而,因 BIS 指数值高而增加麻醉剂量的比例(90%)高于因 BIS 指数值低而减少麻醉剂量的比例(55%):尽管受访者广泛使用 DoA 监测,但在我们的调查中,麻醉人员并未利用 DoA 监测仪提供的所有信息和潜力来指导麻醉剂的滴定。因此,如果麻醉人员能更多地了解如何使用基于脑电图的 DoA 监测来评估和确定患者对麻醉药物的需求,他们将普遍受益。
{"title":"Depth of anesthesia monitoring in Norway-A web-based survey.","authors":"Anders Aasheim, Leiv Arne Rosseland, Ann-Chatrin Linqvist Leonardsen, Luis Romundstad","doi":"10.1111/aas.14420","DOIUrl":"10.1111/aas.14420","url":null,"abstract":"<p><strong>Background: </strong>The bispectral index (BIS) monitor is the most frequently used electroencephalogram (EEG)-based depth of anesthesia (DoA) technology in Norwegian hospitals. However, there is limited knowledge regarding the extent and clinical impact of its use and how anesthesiologists and nurse anesthetists use the information provided by the DoA monitors in their clinical practice.</p><p><strong>Methods: </strong>This cross-sectional survey on the use of DoA monitors in Norway used a web-based questionnaire distributed to anesthesia personnel in all hospitals in Norway. Participation was voluntary and anonymized, and the web form could not track IP sources or respondents' locations.</p><p><strong>Results: </strong>Three hundred and ninety-one nurse anesthetists (n = 324) and anesthesiologists (n = 67) responded. Among the EEG-based DoA monitoring tools, BIS was most often used to observe and assess patients' DoA (98%). Raw EEG waveform analysis (10%), EEG-spectrogram (9%), and suppression rate (10%) were seldom used. Twenty-seven percent of the anesthesia personnel were able to recognize a burst suppression pattern on EEG and its significance. Fifty-eight percent of the respondents considered clinical observations more reliable than BIS. Almost all respondents reported adjusting anesthetic dosage based on the BIS index values (80%). However, the anesthetic dose was more often increased (90%) because of high BIS index values than lowered (55%) because of low BIS index values.</p><p><strong>Conclusion: </strong>Despite our respondents' extensive use of DoA monitoring, the anesthesia personnel in our survey did not use all the information and the potential to guide the titration of anesthetics the DoA monitors provide. Thus, anesthesia personnel could generally benefit from increased knowledge of how EEG-based DoA monitoring can be used to assess and determine individual patients' need for anesthetic medication.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140317594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound in anesthesiology in the Nordic countries-Protocol of an international survey on availability, frequency of use, operator training, and certification. 北欧国家麻醉学中的超声波--关于可用性、使用频率、操作员培训和认证的国际调查协议。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-28 DOI: 10.1111/aas.14482
Martine S Nielsen, Anders M Grejs, Anders B Nielsen, Lars Konge, Anne C Brøchner

Background: Over the past decade, ultrasound utilization has increased within anesthesia and intensive care medicine, enhancing patient safety and diagnostic accuracy. However, the frequency of ultrasound usage and operator training in the Nordic countries remain unclear. This project aims to perform a survey on ultrasound availability, daily clinical use, and how ultrasound skills are trained and assessed, among anesthesiologists.

Methods: This online cross-sectional survey will include anesthesiologists from the Nordic countries. The survey will adhere to the CROSS checklist. Survey items will be developed based on a formative model with a conceptual model, consisting of three main parts, including demographics, ultrasound machines and use, and skills development and assessment. The clinical relevance of items will be secured by including anesthesiologists of various levels of experience in the development of the survey. Furthermore, experienced researchers in medical education will participate in the development, contributing with relevant medical educational perspectives. Data will be summarized using a non-parametric descriptive approach. A chi-squared test will examine relevant relationships between certain answers.

Results: Results will be published in a peer-reviewed journal and presented at relevant scientific conferences and meetings.

Conclusion: This study may find a high availability of ultrasound machines and frequent use in the clinical departments. Despite this expected daily use of ultrasound, missing standardized structured skills acquisition and assessment could be uncovered. The results of this study may contribute to mapping various aspects of clinical ultrasound and skills development for further use in research.

背景:在过去的十年中,超声波在麻醉和重症监护医学中的应用不断增加,从而提高了患者的安全性和诊断的准确性。然而,北欧国家的超声波使用频率和操作员培训情况仍不清楚。本项目旨在对麻醉医师的超声波可用性、日常临床使用情况以及如何培训和评估超声波技能进行调查:这项在线横断面调查将包括北欧国家的麻醉医师。调查将采用 CROSS 核对表。调查项目将根据一个具有概念模型的形成模型进行开发,该模型由三个主要部分组成,包括人口统计学、超声机器和使用以及技能开发和评估。调查项目的临床相关性将通过让不同经验水平的麻醉医师参与调查项目的开发来确保。此外,经验丰富的医学教育研究人员也将参与调查的开发工作,从医学教育的角度提出相关意见。将采用非参数描述性方法对数据进行总结。将采用卡方检验法检验某些答案之间的相关关系:结果:结果将发表在同行评审期刊上,并在相关科学会议上介绍:这项研究可能会发现临床科室中超声波机的普及率很高,使用频率也很高。尽管超声波的日常使用是意料之中的,但仍可能发现缺少标准化的结构化技能学习和评估。这项研究的结果可能有助于绘制临床超声和技能发展的各方面图谱,供进一步研究使用。
{"title":"Ultrasound in anesthesiology in the Nordic countries-Protocol of an international survey on availability, frequency of use, operator training, and certification.","authors":"Martine S Nielsen, Anders M Grejs, Anders B Nielsen, Lars Konge, Anne C Brøchner","doi":"10.1111/aas.14482","DOIUrl":"https://doi.org/10.1111/aas.14482","url":null,"abstract":"<p><strong>Background: </strong>Over the past decade, ultrasound utilization has increased within anesthesia and intensive care medicine, enhancing patient safety and diagnostic accuracy. However, the frequency of ultrasound usage and operator training in the Nordic countries remain unclear. This project aims to perform a survey on ultrasound availability, daily clinical use, and how ultrasound skills are trained and assessed, among anesthesiologists.</p><p><strong>Methods: </strong>This online cross-sectional survey will include anesthesiologists from the Nordic countries. The survey will adhere to the CROSS checklist. Survey items will be developed based on a formative model with a conceptual model, consisting of three main parts, including demographics, ultrasound machines and use, and skills development and assessment. The clinical relevance of items will be secured by including anesthesiologists of various levels of experience in the development of the survey. Furthermore, experienced researchers in medical education will participate in the development, contributing with relevant medical educational perspectives. Data will be summarized using a non-parametric descriptive approach. A chi-squared test will examine relevant relationships between certain answers.</p><p><strong>Results: </strong>Results will be published in a peer-reviewed journal and presented at relevant scientific conferences and meetings.</p><p><strong>Conclusion: </strong>This study may find a high availability of ultrasound machines and frequent use in the clinical departments. Despite this expected daily use of ultrasound, missing standardized structured skills acquisition and assessment could be uncovered. The results of this study may contribute to mapping various aspects of clinical ultrasound and skills development for further use in research.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health status and quality of life before critical illness: Northern Finland Birth Cohort 1966 study. 重病前的健康状况和生活质量:芬兰北部出生队列 1966 年研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-28 DOI: 10.1111/aas.14490
Miikka Niittyvuopio, Siiri Hietanen, Janne Liisanantti, Michael Spalding, Juha Auvinen, Tero Ala-Kokko

Background: Previous findings support the claim intensive care unit (ICU) patients have a higher rate of comorbidities and reduction of health- and functional status compared with the normal population.

Aim: In this prospective observational study, our aim was to determine those health-related factors at the age of 31 years which were associated with a later critical illness among previously un-hospitalized individuals by exploring data obtained from the Northern Finland Birth Cohort 1966 (NFBC1966).

Methods: NFBC1966 is a Finnish birth cohort, which includes 12,058 live births with expected dates of delivery during 1966. The study was conducted among cohort participants who had not been hospitalized for any reason before the cohort follow-up visit at the age of 31. The study group included NFBC1966 participants who were admitted to the ICU of the Oulu University Hospital. The control group included participants who were treated for any reason in regular hospital wards. The data considering the participants' health status and behavior at the age of 31 were collected from the NFBC1966 database. The gathering of ICU and hospitalization data was concluded on December 31, 2016.

Results: 849 NFBC1966 participants met the inclusion criteria: 69 were treated in the ICU (study group) and 780 on regular hospital wards (controls). In the study group, the rate of neurological diseases (26% vs. 16%, 95% CI: -21.8%, -0.2%), malignancy (3% vs. 0.7%, 95% CI: -9.7%, 0.0%), alcohol abuse (4.5% vs. 1%, 95% CI: -11.5%, -0.3%) and smoking (77% vs. 65%, 95% CI: -21.6%, -0.3%) were higher compared with the control group. The patients in the ICU group were also more prone to violent injuries, (17% vs. 7%, 95% CI: -20.2%, -1.9%), practiced less hard physical activity (65% vs. 78%, 95% CI: 2.1%, 25.3%) and had lower maximal muscle strength according to the hand grip test (30 vs. 34 kg, 95% CI: -8.2, 8.6 kg).

Conclusions: In this study examining previously un-hospitalized patients, the main factors associated with future critical illness were neurological comorbidities, malignancy, alcohol misuse, smoking, low maximum muscle strength, and less frequent physical exercise compared with those with hospitalization not requiring ICU admission.

背景:以前的研究结果表明,重症监护病房(ICU)患者与正常人相比,合并症发生率更高,健康状况和功能状态也有所下降:目的:在这项前瞻性观察研究中,我们的目的是通过研究1966年芬兰北部出生队列(NFBC1966)中的数据,确定在31岁时与以前未住院的人后来患危重病有关的健康相关因素:NFBC1966是一个芬兰出生队列,包括12 058名预产期在1966年的活产婴儿。研究对象是在31岁进行队列随访之前未因任何原因住院的队列参与者。研究组包括入住奥卢大学医院重症监护室的 NFBC1966 参与者。对照组包括因任何原因在普通病房接受治疗的参与者。研究人员从 NFBC1966 数据库中收集了参与者 31 岁时的健康状况和行为数据。重症监护室和住院数据的收集工作于2016年12月31日结束:849名NFBC1966参与者符合纳入标准:69人在重症监护室接受治疗(研究组),780人在普通病房接受治疗(对照组)。与对照组相比,研究组中患神经系统疾病(26% 对 16%,95% CI:-21.8%,-0.2%)、恶性肿瘤(3% 对 0.7%,95% CI:-9.7%,0.0%)、酗酒(4.5% 对 1%,95% CI:-11.5%,-0.3%)和吸烟(77% 对 65%,95% CI:-21.6%,-0.3%)的比例更高。重症监护室组患者也更容易受到暴力伤害(17% 对 7%,95% CI:-20.2%,-1.9%),较少进行剧烈运动(65% 对 78%,95% CI:2.1%,25.3%),手部握力测试显示的最大肌力较低(30 kg 对 34 kg,95% CI:-8.2,8.6 kg):在这项针对既往未住院患者的研究中,与不需要入住重症监护室的住院患者相比,与未来危重病相关的主要因素包括神经系统合并症、恶性肿瘤、酗酒、吸烟、最大肌力较低以及较少进行体育锻炼。
{"title":"Health status and quality of life before critical illness: Northern Finland Birth Cohort 1966 study.","authors":"Miikka Niittyvuopio, Siiri Hietanen, Janne Liisanantti, Michael Spalding, Juha Auvinen, Tero Ala-Kokko","doi":"10.1111/aas.14490","DOIUrl":"https://doi.org/10.1111/aas.14490","url":null,"abstract":"<p><strong>Background: </strong>Previous findings support the claim intensive care unit (ICU) patients have a higher rate of comorbidities and reduction of health- and functional status compared with the normal population.</p><p><strong>Aim: </strong>In this prospective observational study, our aim was to determine those health-related factors at the age of 31 years which were associated with a later critical illness among previously un-hospitalized individuals by exploring data obtained from the Northern Finland Birth Cohort 1966 (NFBC1966).</p><p><strong>Methods: </strong>NFBC1966 is a Finnish birth cohort, which includes 12,058 live births with expected dates of delivery during 1966. The study was conducted among cohort participants who had not been hospitalized for any reason before the cohort follow-up visit at the age of 31. The study group included NFBC1966 participants who were admitted to the ICU of the Oulu University Hospital. The control group included participants who were treated for any reason in regular hospital wards. The data considering the participants' health status and behavior at the age of 31 were collected from the NFBC1966 database. The gathering of ICU and hospitalization data was concluded on December 31, 2016.</p><p><strong>Results: </strong>849 NFBC1966 participants met the inclusion criteria: 69 were treated in the ICU (study group) and 780 on regular hospital wards (controls). In the study group, the rate of neurological diseases (26% vs. 16%, 95% CI: -21.8%, -0.2%), malignancy (3% vs. 0.7%, 95% CI: -9.7%, 0.0%), alcohol abuse (4.5% vs. 1%, 95% CI: -11.5%, -0.3%) and smoking (77% vs. 65%, 95% CI: -21.6%, -0.3%) were higher compared with the control group. The patients in the ICU group were also more prone to violent injuries, (17% vs. 7%, 95% CI: -20.2%, -1.9%), practiced less hard physical activity (65% vs. 78%, 95% CI: 2.1%, 25.3%) and had lower maximal muscle strength according to the hand grip test (30 vs. 34 kg, 95% CI: -8.2, 8.6 kg).</p><p><strong>Conclusions: </strong>In this study examining previously un-hospitalized patients, the main factors associated with future critical illness were neurological comorbidities, malignancy, alcohol misuse, smoking, low maximum muscle strength, and less frequent physical exercise compared with those with hospitalization not requiring ICU admission.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey of emergency medical service providers' perspectives regarding relatives influence on acute prehospital treatment of adult patients. 急诊医疗服务提供者对亲属对成人患者急性院前治疗影响的看法调查。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-06-27 DOI: 10.1111/aas.14480
Marie Glad, Ingeborg R Grønlund, Ann Merete Møller

Background: In the field of prehospital emergency medicine, specialized emergency medical service (EMS) providers interact with acutely ill patients and their relatives. The influence of family presence during in-hospital resuscitation is well described. However, no studies have previously assessed the influence of relatives' presence in the acute prehospital setting. The aim of this study was to investigate EMS providers' perspectives on relatives' impact on the acute prehospital treatment of adult patients.

Methods: An online anonymous survey was distributed to all prehospital EMS providers in the Capital Region of Denmark. The survey included 25 research questions on a 5-point Likert scale, investigating relatives' influence on treatment in three different domains: positive, negative, and resuscitation. A higher domain score indicates a high level of agreement or frequency.

Results: Two hundred forty-six EMS providers completed the survey (84 ambulance technicians, 87 paramedics, and 75 physicians). There were no significant differences in the positive domain across professions (p = .175). Physicians had a statistically significant lower median score in the negative domain, compared with ambulance technicians and paramedics (2.50 vs. 2.63 and 2.63, p = .024). In the resuscitation domain, paramedics and physicians had a significant lower median score compared with ambulance technicians (3.00 and 3.00 vs. 3.14, p = .003).

Conclusion: All professions were equally positive towards the relatives' presence and involvement in the acute prehospital setting. Physicians were less likely to be negatively influenced by the presence of relatives compared with ambulance technicians and paramedics. In all professions, increased experience led to improved comfort with handling relatives.

背景:在院前急救医学领域,专业的急救医疗服务提供者会与急症患者及其亲属进行互动。家属在场对院内复苏的影响已被充分描述。然而,此前还没有研究评估过亲属在场对院前急救的影响。本研究旨在调查急救医疗服务提供者对亲属对成人患者急性院前治疗的影响的看法:向丹麦首都地区的所有院前急救服务提供者发放了一份在线匿名调查问卷。调查包括 25 个研究问题,采用 5 分制李克特量表,调查亲属在积极、消极和复苏三个不同领域对治疗的影响。领域得分越高,表明同意程度或频率越高:246 名急救服务提供者(84 名救护技术人员、87 名护理人员和 75 名医生)完成了调查。不同职业在积极领域没有明显差异(p = .175)。与救护技术人员和护理人员相比,医生在消极领域的中位数得分明显较低(2.50 vs. 2.63 和 2.63,p = .024)。在复苏领域,辅助医务人员和医生的中位数得分明显低于救护技术人员(3.00 和 3.00 vs. 3.14,p = .003):结论:所有职业对亲属在急性院前环境中的存在和参与都持同样积极的态度。与救护技术人员和护理人员相比,医生不太可能受到亲属在场的负面影响。在所有职业中,经验的增加会提高处理亲属的舒适度。
{"title":"A survey of emergency medical service providers' perspectives regarding relatives influence on acute prehospital treatment of adult patients.","authors":"Marie Glad, Ingeborg R Grønlund, Ann Merete Møller","doi":"10.1111/aas.14480","DOIUrl":"https://doi.org/10.1111/aas.14480","url":null,"abstract":"<p><strong>Background: </strong>In the field of prehospital emergency medicine, specialized emergency medical service (EMS) providers interact with acutely ill patients and their relatives. The influence of family presence during in-hospital resuscitation is well described. However, no studies have previously assessed the influence of relatives' presence in the acute prehospital setting. The aim of this study was to investigate EMS providers' perspectives on relatives' impact on the acute prehospital treatment of adult patients.</p><p><strong>Methods: </strong>An online anonymous survey was distributed to all prehospital EMS providers in the Capital Region of Denmark. The survey included 25 research questions on a 5-point Likert scale, investigating relatives' influence on treatment in three different domains: positive, negative, and resuscitation. A higher domain score indicates a high level of agreement or frequency.</p><p><strong>Results: </strong>Two hundred forty-six EMS providers completed the survey (84 ambulance technicians, 87 paramedics, and 75 physicians). There were no significant differences in the positive domain across professions (p = .175). Physicians had a statistically significant lower median score in the negative domain, compared with ambulance technicians and paramedics (2.50 vs. 2.63 and 2.63, p = .024). In the resuscitation domain, paramedics and physicians had a significant lower median score compared with ambulance technicians (3.00 and 3.00 vs. 3.14, p = .003).</p><p><strong>Conclusion: </strong>All professions were equally positive towards the relatives' presence and involvement in the acute prehospital setting. Physicians were less likely to be negatively influenced by the presence of relatives compared with ambulance technicians and paramedics. In all professions, increased experience led to improved comfort with handling relatives.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Anaesthesiologica Scandinavica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1